Study for the low and intermediate risk of Neuroblastoma

Phase 1

• Conditions: INTERMEDIATE AND LOW RISK NEUROBLASTOMA; Therapeutic area: Diseases [C] - Cancer [C04]

• Registration Number: EUCTR2010-021396-81-AT
• Lead Sponsor: INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE VALENCIA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-09
• Last Update Posted: 28 February 2019

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Not specified
• Target Recruitment: 685

Inclusion Criteria

The inclusion criteria depend on the subgroup that the patient is assigned to and can be found in the protocol
Are the trial subjects under 18? yes
Number of subjects for this age range: 685
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

The exclusion criteria depend on the subgroup that the patient is assigned to and can be found in the protocol

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified